CBN for Sleep
Brand: Injoy Extracts
Flavor: Blu Razz
4oz Jar | 30 Gummies| 600mg Total
Contents Per Gummy
- 10mg CBN per gummy
- 10mg CBG per gummy
Contents Per Jar
- 300mg CBN per Jar
- 300mg CBG per jar
- Made with Hemp-Derived CBN Isolate
- Made with Hemp-Derived CBG Isolate
- No artificial colors or flavors
- Made in the USA
What Is CBG
In the young hemp plant, CBG acts as the first form of CBD, THC, and cannabichromene (CBC). CBG is a member of the CBG group of cannabinoids that includes cannabigerol acid (CBGA). The enzymes in a young hemp plant turn CBGA into cannabidiol acid (CBDA), tetrahydrocannabinol acid (THCA), or cannabichromene acid (CBCA). These acids then break down into CBD, CBC, or THC.
Research suggests that CBG can kill bacteria, reduce inflammation, relieve pain, and resolve even more symptoms. Read More
What Exactly Does CBN Cannabinoid Do?
Once CBN is inside the body, the molecular compound naturally bonds with specific receptors in the body’s endocannabinoid system. A wide range of our body’s physiological functions and responses are managed by this complex system, including mood, pain perception, appetite, and cognitive functions. CBN helps the receptors in this system do what’s needed to invigorate all kinds of desirable changes, to give you a sense of balance and relief.
How Do You Use CBN?
If you’ve been looking for a natural sleep-aid, pain reliever, or stress relief, CBN is definitely worth a try. You can use it as a tincture, mix it into teas or smoothies, or apply it topically. Just as with all new modalities, it’s best to start low and slow with plant-based medicines. Everyone has different physiology and will metabolize CBN uniquely. Keep track of your dosages and note your moods, aches, and pains until you find a system that works for you.
CBN Cannabinoid Benefits
The current research on CBN shows some potential for a range of uses, despite its weak impact on the central immune system. Studies are scarce, but clinical trials are currently being conducted on its potential for pain relief compared to opiates and placebo. Here are some of its more well-established benefits based on the current research.
A 2008 study tested cannabinol along with four other cannabinoids for antibacterial properties. Researchers report “potent activity against a variety of MRSA strains of current clinical relevance.” They also found that cannabinol fought bacteria indirectly, but the study revealed the antibacterial potential for CBN and other cannabinoids, including CBD, CBC, CBG, and THC.
One of the more well-known effects of cannabis is referred to as “the munchies.” This is normally attributed to its THC content. However, a 2012 study shows the potential for CBN to stimulate appetite without the psychoactive consequences. According to the study, “This is the first time cannabinol (CBN) has been shown to increase feeding. Therefore, cannabinol could, in the future, provide an alternative to the currently used and psychotropic ∆9THC-based medicines since cannabinol is currently considered to be non-psychotropic.”
Another potential benefit of cannabinol is its application for fighting inflammation. A 1974 study conducted on lab rats “demonstrated the anti‐inflammatory actions of a crude extract of THC and the non-psychoactive Cannabis constituents cannabidiol (CBD) and cannabinol. Further research needs to be conducted to determine the individual effectiveness of each cannabinoid.
It has been said that cannabis can help with glaucoma. Is it true? When Israeli scientists explored this claim in 2007, they found that CBN positively affected OHT or ocular hypertension. OHT is the most important risk factor for glaucoma. “THC, CBN, and nabilone were active in lowering intraocular pressure (IOP) in rabbits, while CBD was inactive."
A study on the effects of cannabinol on amyotrophic lateral sclerosis in mice was conducted in 2005. Scientists said, “CBN was delivered via subcutaneously implanted osmotic mini-pumps (5 mg/kg/day) over a period of up to 12 weeks. We found that this treatment significantly delays disease onset by more than two weeks…”. More research is needed. Still, cannabinol could be a possible option for what is considered “the most common adult-onset motor neuron disorder.”